艾美捷科技代理Akina品牌全系列产品

Akina, Inc. 于2001年成立，是一家具有多年经营历史的公司，PolyScitech作为其旗下部门，依托公司的资源和平台开展业务。由Kinam Park博士创立，他是普渡大学生物医学工程与药剂学教授。Kinam Park博士在相关学术领域具有深厚的造诣和丰富的经验，这为PolyScitech部门在技术研发和专业方向上提供了坚实的学术支持和引领。Akina公司的产品线包括：PolySciTech Polymers、PURASORB® Polymers、Viatel™m Polymers、VIVOS™ PLGA-g-PEG、PLGA/PLA Standards、NuPlonTm、AquaGel@ Hydrogels、PET Prepolymer、Flamma Fluor Fluorescent Dyes、Kitopure Chitosan、3DCellMaker。

Akinalytics作为Akina, Inc.的部门，专门从事控释药物输送系统以及可生物降解聚合物及其制药/生物医学应用。提供快速周转和具有竞争力的价格的样品分析，包括FTIR分光光度法、紫外/可见分光光度法、GPC、调制差示扫描量热法、流变分析、机械/纹理分析、光学分析等。

▍Akina公司产品线

● PolySciTech Polymers：提供各种类型的聚合物产品，广泛应用于科研和工业领域

● PURASORB® Polymers：由于Corbion和Akina, Inc. (PolySciTech) 之间的分销关系，Purasorb®聚合物现作为研究产品提供，简化开发项目。用于长效注射剂、医疗器械等，为GMP制造的产品提供临床转化的直接途径。

● Viatel™ Polymers：精选开发产品，得益于Ashland和Akina, Inc. (PolySciTech) 之间的分销关系。无最低订购量要求，购买时间快，便利开发需求。

●  VIVOS™ PLGA-g-PEG：使用聚丙交酯-乙醇共聚酯-接枝-聚乙二醇组成的快速溶解、可生物降解的热凝胶输送活性药物。由Vivos, Inc.和Akina, Inc.合作开发，简化药物递送开发。

产品应用：这些聚合物产品具有多种应用，包括但不限于阴离子药物/核酸衍生物的递送；纳米通道和纳米孔的形成；形成“隐形”聚乙二醇化微粒；聚合物混合物的塑化（不溶性）；用于改性/交联的短链树脂；热凝胶化；药物的水溶性

▍Akina部分产品列表

艾美捷科技代理BioGenex品牌产品。

Biogenex位于美国旧金山，是抗原修复的发明者，是致力于研发生产准确、可靠、可重复性的高效检测方法的自动化和标准化的先驱。BioGenex拥有全面的免疫组化全自动处理系统，包括i1000抗原修复系统、i6000自动染色仪、iVISION数码成像分析系统等，具有检测诊断的高度一致性，为科研和临床诊治提供高质量的参考依据。Biogenx i 系列免疫组化全自动处理系统是使您的科研和临床病理诊断国际化的最佳途径。

BioGenex is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining. We develop, manufacture and market automated slide-based staining instruments and offer a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR.

BioGenex的主要产品包括：

（1）IHC

Automation

Primary Antibodies

Antigen Retrieval & Dewax

Detection Systems

Controls

Ancillaries

（2）ISH/CISH

Automation

ISH/CISH Probes

Nucleic Retrieval & Dewax

Detection Systems

Ancillaries

（3）FISH

eFISH Automation

eFISH Probes

Nucleic Retrieval & Dewax

eFISH Visualization Kits

eFISH Ancillaries

（4）miRNA

miRNA Automation

miRNA Probes & Controls

Nucleic Retrieval & Dewax

Detection Systems

Ancillaries

（5）Multiplexing & Double Staining

Automation

Antibody Cocktails

Multiplexing

Antigen Retrieval & Dewax

Detection Systems

Ancillaries

（6）Special Stains

Automation

Special Stains

Ancillaries

（7）In Situ PCR

（8）1IF

Dendritics公司主要关注人类树突状细胞，希望找到能够促使CD34+造血前体细胞转化为树突状细胞（在GM-CSF和TNF-alpha存在的情况下）的细胞因子。在1992-2005年间，大量的研究使得研究者对人类树突状细胞的产生、细胞通路、C-type凝集素受体的功能及Toll-like受体的活性有了更深的理解。

DENDRITICS was started in 2005 by former members of SCHERING PLOUGH Laboratory for Immunological Research (LIR) in Dardilly, France. From their long experience at LIR, the team members of DENDRITICS have gathered complementary scientific and technological knowledge in different areas of immunology. The initial focus of LIR was in the biology of B lymphocytes, elaboration of human monoclonal antibodies, and in cytokine discovery (IL-3, IL-4, IL-7, IL-10, IL-17, GM-CSF) together with our colleagues of DNAX Research Institute in Palo Alto, California.

Our interest in cytokines led to the finding that human dendritic cells (DCs) could be generated in vitro from CD34+ hematopoietic progenitors cultured in the presence of GM-CSF and TNF-alpha.

The period from 1992 to 2005 saw the specialization of LIR in DC biology and was fuelled by a large-scale effort to discover and study the function of genes specifically expressed by these cells. This program led to a number of findings that contributed in particular to understanding the heterogeneity of DCs, the pathways regulating DC migration, the function of C-type lectin receptors in DCs and the activity of Toll-like receptors in DCs. Many novel genes were discovered through screening of cDNA libraries or through monoclonal antibodies raised against DCs.

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com